revenue $1.08B, net income -$77.9M. Cooper logs embryo-media litigation charge; IT controls fixed, U.K. tax appeal pending

Filed June 5, 2026 · Period ending April 30, 2026 · Compared to 10-Q May 30, 2025 · ~2 min read

Key Changes

• high

  CooperSurgical recorded $271.6M net litigation expense ($324.1M liability less $52.5M insurance) for embryo culture media recall claims—over 140 lawsuits and 1,500 claimants now exceed available insurance coverage, swinging the segment to operating loss.

  Legal Proceedings / MD&A: Litigation verify on EDGAR →
• high

  U.K. tax tribunal ruled against Cooper on 2014 Sauflon payroll tax dispute; company is appealing but faces potential liability of £71.7M plus interest if unsuccessful.

  Legal Proceedings verify on EDGAR →
• high

  Material weakness in IT general controls for CooperSurgical U.S. operations has been remediated; disclosure controls now deemed effective as of April 30, 2026.

  Controls and Procedures verify on EDGAR →